文献速递胸部CT

无定位像固定剂量超低剂量CT检测肺结节的前瞻性研究

Detection of pulmonary nodules with scoutless fixed-dose ultra-low-dose CT: a prospective study.
PubMed 文献 · Eur Radiol · 2022-03-03

前瞻性纳入63例患者,比较无定位像固定剂量超低剂量CT与标准剂量CT对肺结节的检出及半自动测量准确性。超低剂量CT对大于50 mm³结节检出率与标准剂量CT无显著差异,对小于50 mm³结节检出率显著降低;计算体积平均小0.03 mL或9%,NODCAT分级一致率84%。

要点

  • 超低剂量CT对大于50 mm³实性肺结节的检出率与标准剂量CT无显著差异
  • 对小于50 mm³结节,超低剂量CT检出率较标准剂量CT显著降低
  • 超低剂量CT计算的结节体积和直径偏小,但NODCAT分级一致率84%

核心结论

  • 无定位像固定剂量超低剂量CT可可靠检出肺癌筛查中临床相关体积(大于50 mm³)的实性肺结节,且不受患者体型影响;对小于50 mm³结节检出率低于标准剂量CT,用于肺转移瘤检测时应个案考虑。

研究设计与样本

  • 前瞻性研究,63例患者接受超低剂量CT和标准剂量CT,两位阅片者视觉及计算机辅助检测(CAD)阅片,以标准剂量CT共识检出的结节为参考标准,按NELSON试验NODCAT分类。

诊断标准与关键数值

  • 参考标准共173个结节;NODCAT 3和4且大于50 mm³结节,阅片者1超低剂量CT检出率93% vs 标准剂量CT 89%(p=0.257),阅片者2为96% vs 98%(p=0.317);NODCAT 1和2且小于50 mm³结节,阅片者1为66% vs 80%(p=0.023),阅片者2为77% vs 87%(p=0.039)。

临床应用与阅片要点

  • 超低剂量CT方案为无定位像、固定剂量,CTDIvol 0.15 mGy;体重指数和胸围不影响结节检出率(p=0.229和p=0.362)。

局限性

  • 超低剂量CT对小于50 mm³结节检出率低于标准剂量CT,用于肺转移瘤检测时应个案考虑。
  • 超低剂量CT计算的结节体积和直径较标准剂量CT小(p<0.0001),但未改变NODCAT分级(一致率84%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To determine the accuracy of scoutless, fixed-dose ultra-low-dose (ULD) CT compared to standard-dose (SD) CT for pulmonary nodule detection and semi-automated nodule measurement, across different patient sizes.

METHODS: Sixty-three patients underwent ULD and SD CT. Two readers examined all studies visually and with computer-aided detection (CAD). Nodules detected on SD CT were included in the reference standard by consensus and stratified into 4 categories (nodule category, NODCAT) from the Dutch-Belgian Lung Cancer Screening trial (NELSON). Effects of NODCAT and patient size on nodule detection were determined. For each nodule, volume and diameter were compared between both scans.

RESULTS: The reference standard comprised 173 nodules. For both readers, detection rates on ULD versus SD CT were not significantly different for NODCAT 3 and 4 nodules > 50 mm3 (reader 1: 93% versus 89% (p = 0.257); reader 2: 96% versus 98% (p = 0.317)). For NODCAT 1 and 2 nodules < 50 mm3, detection rates on ULD versus SD CT dropped significantly (reader 1: 66% versus 80% (p = 0.023); reader 2: 77% versus 87% (p = 0.039)). Body mass index and chest circumference did not influence nodule detectability (p = 0.229 and p = 0.362, respectively). Calculated volumes and diameters were smaller on ULD CT (p < 0.0001), without altering NODCAT (84% agreement).

CONCLUSIONS: Scoutless ULD CT reliably detects solid lung nodules with a clinically relevant volume (> 50 mm3) in lung cancer screening, irrespective of patient size. Since detection rates were lower compared to SD CT for nodules < 50 mm3, its use for lung metastasis detection should be considered on a case-by-case basis.

KEY POINTS: • Detection rates of pulmonary nodules > 50 mm3are not significantly different between scoutless ULD and SD CT (i.e. volumes clinically relevant in lung cancer screening based on the NELSON trial), but were different for the detection of nodules < 50 mm3(i.e. volumes still potentially relevant in lung metastasis screening). • Calculated nodule volumes were on average 0.03 mL or 9% smaller on ULD CT, which is below the 20-25% interscan variability previously reported with software-based volumetry. • Even though a scoutless, fixed-dose ULD CT protocol was used (CTDIvol0.15 mGy), pulmonary nodule detection was not influenced by patient size.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Gheysens, De Wever, Cockmartin, et al. Detection of pulmonary nodules with scoutless fixed-dose ultra-low-dose CT: a prospective study. Eur Radiol. 2022. PMID: 35238969. doi:10.1007/s00330-022-08584-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。